Wilks Farris

Director · Ten-percent owner · ACDC, DWSN

As of 2026-09-16, Wilks Farris has 8 Form 4 transactions on record across 2 companies — 3 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $19.8MIndirect: $5.2M$25.0Mas of 2026-09-16
  • Direct $19.8M
  • Indirect $5.2M
ACDCdirect4,096,512 sh$19.8M
ACDCindirect1,071,454 sh$5.2M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

ACDC · 6 trades
2026-06-25: Other acquisition, 1,071,454 sh ($5.1M)2025-09-09: Other acquisition, 431,380 sh ($0)2025-09-09: Other acquisition, 977,771 sh ($0)2025-08-14: Purchase, 2,500,000 sh ($10.0M)2025-03-10: Sale, 1,000 sh ($1.0M)2025-02-26: Purchase, 338,756 sh ($2.3M)
DWSN · 2 trades
2025-12-31: Other acquisition, 15,547,010 sh2025-12-31: Other acquisition, 15,547,010 sh

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-08-14ACDCPurchase2,500,000 @ $4.00$10.0M+214.6% of holding3,665,132Form 4
2025-03-10ACDCSale1,000 @ $1000.00$1.0M−5.0% of holding19,000Form 4
2025-02-26ACDCPurchase338,756 @ $6.93$2.3M+34.6% of holding1,316,534Form 4
5 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-25ACDCOther acquisition1,071,4541,071,454Form 4
2025-12-31DWSNOther acquisition15,547,010Form 4
2025-12-31DWSNOther acquisition15,547,010Form 4
2025-09-09ACDCOther acquisition431,3804,096,512Form 4
2025-09-09ACDCOther acquisition977,7717Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.